BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,670,383 | -70.6% | 930,447 | -48.3% | 0.06% | -69.6% |
| Q2 2023 | $9,090,000 | +41.3% | 1,800,000 | +136.8% | 0.19% | +54.0% |
| Q3 2021 | $6,431,000 | -49.6% | 760,128 | -27.4% | 0.13% | -44.5% |
| Q2 2021 | $12,770,000 | -49.8% | 1,047,599 | 0.0% | 0.23% | -57.5% |
| Q1 2021 | $25,415,000 | -1.2% | 1,047,599 | +30.5% | 0.53% | +5.1% |
| Q4 2020 | $25,720,000 | +6.0% | 802,511 | 0.0% | 0.51% | -14.0% |
| Q3 2020 | $24,260,000 | +7.4% | 802,511 | +49.7% | 0.59% | -10.2% |
| Q2 2020 | $22,598,000 | +69.0% | 536,001 | 0.0% | 0.66% | +55.2% |
| Q1 2020 | $13,373,000 | – | 536,001 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |